Coating Place, a U.S.-based CDMO, has secured a strategic investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm.

Coating Place provides microencapsulation services leveraging its proprietary equipment and processes, scalability, and ability to support customers from product formulation through commercial manufacturing. 

The investment will enable Coating Place to scale operations to meet growing demand for its services across pharmaceutical, nutraceutical, animal health, and industrial markets.

“This investment marks an exciting milestone for Coating Place as we celebrate our 50th anniversary and prepare for the next chapter of growth,” said Tim Breunig, Chief Executive Officer of Coating Place. “We are excited to partner with 1315 Capital. Combined with their industry expertise and strategic growth mindset, we will accelerate growth across the many industries we serve.”

“Coating Place has a compelling opportunity to scale its best-in-class platform, offering highly specialized services and deep technical expertise for customers developing complex modified-release products,” said Matthew Reber, Partner at 1315 Capital. “We’re proud to partner with Tim and his team as the company expands its commercial reach in order to serve the large and growing need for its services.”